Login / Signup
FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism.
Shufen Wang
Yan Ma
Yi Hu
Xia Zhao
Yilin Li
Shuming Ouyang
Guifang Luo
Published in:
Journal of ovarian research (2023)
Taken together, we unveil a novel FOXD3/miR-335/DAAM1/myosin II axis that regulates the chemoresistance of OC both in vitro and in vivo.
Keyphrases
</>
cell proliferation
long non coding rna
long noncoding rna
binding protein
photodynamic therapy
combination therapy